Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AHPA Weight-Loss Ad Draft Guidelines Include Prohibited Statements

This article was originally published in The Tan Sheet

Executive Summary

The American Herbal Products Association's voluntary guidelines governing the advertising of weight-loss dietary supplements could include a requirement that a product's active ingredient be identified in ads

You may also be interested in...



Weight-Loss Supplement Ads Should Include Warnings, Qualifiers – AHPA

Companies marketing weight-loss supplements should disclose any warnings for their products when making statements in advertising "relative to the product's safety," according to draft guidelines released by the American Herbal Products Association May 18

Weight-Loss Supplement Ads Should Include Warnings, Qualifiers – AHPA

Companies marketing weight-loss supplements should disclose any warnings for their products when making statements in advertising "relative to the product's safety," according to draft guidelines released by the American Herbal Products Association May 18

Weight-Loss Supplement Ads Should Include Warnings, Qualifiers – AHPA

Companies marketing weight-loss supplements should disclose any warnings for their products when making statements in advertising "relative to the product's safety," according to draft guidelines released by the American Herbal Products Association May 18

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS094807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel